Transient effect of topical treatment of cutaneous leishmaniasis with imiquimod.
about
Clinical status of agents being developed for leishmaniasisFirst-line therapy for human cutaneous leishmaniasis in Peru using the TLR7 agonist imiquimod in combination with pentavalent antimonyTopical resiquimod protects against visceral infection with Leishmania infantum chagasi in mice.Efficacy of an immune modulator in experimental Chlamydia trachomatis infection of the female genital tract.Therapeutic options for cutaneous leishmaniasis.Old World cutaneous leishmaniasis: diagnosis and treatmentCutaneous and mucocutaneous leishmaniasis: emerging therapies and progress in disease management.Drug delivery systems for the topical treatment of cutaneous leishmaniasis.Nanoemulsions containing a synthetic chalcone as an alternative for treating cutaneous leshmaniasis: optimization using a full factorial designImiquimod in dermatology: an overview.Repurposing as a strategy for the discovery of new anti-leishmanials: the-state-of-the-art.Efforts to counteract locally the effects of systemic immunosupression: a review on the use of imiquimod, a topical immunostimulator in organ transplant recipients.
P2860
Q28279390-EB112020-17EC-4C03-AEA2-704F5078ABB4Q28475794-268F55F3-BA5F-487A-A38E-40E187C31C89Q34260736-2BE37479-7358-44E7-8210-74D12EFEE36EQ35056798-B4A8FB86-574F-4EE2-9E5F-58B7F0121C37Q36829628-2D1B6B96-486E-419A-9647-08C997FD4CDBQ37010084-455F3193-5800-415C-B927-9CC692D73448Q37693923-0CDFED0F-394C-4B82-8738-DF347C20CE8BQ38020882-5B9AC1AB-EF09-4B07-8A81-75EED2CA03C3Q38835591-B5FB5EC1-E0AE-4A6D-88DE-24D0CB87A4A7Q38888889-2D3C5506-9F9C-4ECD-95D7-D30D4C2E0D99Q38939544-9A1C9C17-163C-4A3A-8CD1-E577DA77B38CQ42474649-223E8C2E-4DFC-45DB-8AA6-8278E07B7424
P2860
Transient effect of topical treatment of cutaneous leishmaniasis with imiquimod.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Transient effect of topical treatment of cutaneous leishmaniasis with imiquimod.
@en
Transient effect of topical treatment of cutaneous leishmaniasis with imiquimod.
@nl
type
label
Transient effect of topical treatment of cutaneous leishmaniasis with imiquimod.
@en
Transient effect of topical treatment of cutaneous leishmaniasis with imiquimod.
@nl
prefLabel
Transient effect of topical treatment of cutaneous leishmaniasis with imiquimod.
@en
Transient effect of topical treatment of cutaneous leishmaniasis with imiquimod.
@nl
P2093
P2860
P1476
Transient effect of topical treatment of cutaneous leishmaniasis with imiquimod.
@en
P2093
Johannes Pammer
Josef Seeberger
Saleh Daoud
P2860
P304
P356
10.1046/J.1365-4362.2003.01955.X
P577
2003-07-01T00:00:00Z